Mifepristone (RU 486) for Alzheimer's disease.
Publication
, Journal Article
Pomara, N; Doraiswamy, PM; Tun, H; Ferris, S
Published in: Neurology
May 14, 2002
Duke Scholars
Published In
Neurology
DOI
ISSN
0028-3878
Publication Date
May 14, 2002
Volume
58
Issue
9
Start / End Page
1436
Location
United States
Related Subject Headings
- Treatment Outcome
- Receptors, Glucocorticoid
- Pilot Projects
- Neuropsychological Tests
- Neurology & Neurosurgery
- Mifepristone
- Male
- Hypokalemia
- Humans
- Hormone Antagonists
Citation
APA
Chicago
ICMJE
MLA
NLM
Pomara, N., Doraiswamy, P. M., Tun, H., & Ferris, S. (2002). Mifepristone (RU 486) for Alzheimer's disease. Neurology, 58(9), 1436. https://doi.org/10.1212/wnl.58.9.1436
Pomara, Nunzio, P Murali Doraiswamy, Hla Tun, and Steven Ferris. “Mifepristone (RU 486) for Alzheimer's disease.” Neurology 58, no. 9 (May 14, 2002): 1436. https://doi.org/10.1212/wnl.58.9.1436.
Pomara N, Doraiswamy PM, Tun H, Ferris S. Mifepristone (RU 486) for Alzheimer's disease. Neurology. 2002 May 14;58(9):1436.
Pomara, Nunzio, et al. “Mifepristone (RU 486) for Alzheimer's disease.” Neurology, vol. 58, no. 9, May 2002, p. 1436. Pubmed, doi:10.1212/wnl.58.9.1436.
Pomara N, Doraiswamy PM, Tun H, Ferris S. Mifepristone (RU 486) for Alzheimer's disease. Neurology. 2002 May 14;58(9):1436.
Published In
Neurology
DOI
ISSN
0028-3878
Publication Date
May 14, 2002
Volume
58
Issue
9
Start / End Page
1436
Location
United States
Related Subject Headings
- Treatment Outcome
- Receptors, Glucocorticoid
- Pilot Projects
- Neuropsychological Tests
- Neurology & Neurosurgery
- Mifepristone
- Male
- Hypokalemia
- Humans
- Hormone Antagonists